Growth Opportunities in the APAC IVD Market, Forecast to 2021

Growth Opportunities in the APAC IVD Market, Forecast to 2021

Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market

RELEASE DATE
19-Jun-2017
REGION
Asia Pacific
Research Code: P97C-01-00-00-00
SKU: HC02831-AP-MT_20286

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02831-AP-MT_20286

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016.

Research Scope:
•     Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions:
o     Immunochemistry
o     Self-monitoring Blood Glucose (SMBG) Meter
o     Hematology
o     Point-of-care Testing (POCT)
o     Tissue Diagnostics
o     Hemostasis
o     Clinical Microbiology
o     Molecular Diagnostics

•     Regional trends in APAC; it covers China, India, Japan, Australia, South Korea, and member states of the Association of Southeast Asian Nations (ASEAN)

The APAC IVD industry is undergoing major transformation. Paradigm shifts in the Asian healthcare ecosystem are driving the future of the IVD industry with stellar growth rates and rampant uptake of innovative technologies. Market penetration of molecular diagnostic (MDx) tests in infectious disease diagnosis, laboratory automation for high throughput operational efficiency, and digital pathology are three major themes that will impact the future of clinical pathology in Asia. The spurt in the number of private healthcare sectors and market shift towards quality care, private insurance, and high demand for medical tourism have led Asia to be on par with western counterparts in terms of availability and access to novel technologies. However, given the huge potential and market opportunities, there remain significant challenges in the complex market with preferential demands in Asian countries and fluidic regulatory and market access networks that pose significant challenges for operating companies. The APAC IVD industry, worth $ 14.44 billion in 2016, is expected to reach $19.64 billion in 2021 growing at a CAGR of 6.3%. In molecular diagnostics, infectious disease has the highest market share of 72.0%, followed by oncology (14.3%), genetic disorders (10.0%), and pharmacogenomics (3.7%). Digital innovations in the IVD industry, such as digital pathology, precision medicine, and health analytics are radically changing the care continuum in APAC. The IVD market is moving towards total laboratory automation from task-targeted automation. Although stand-alone automation systems are cost effective in clinical labs, multiple stakeholders in the healthcare ecosystems including physicians, payers, and administrators demand “connected-pathology solutions.”

Key Questions This Study will Answer:
1.     What is the current IVD market scenario in Asia?
2.     What are the emerging segments in Asia?
3.     What are the hot beds in Asia for investment in diagnostics?
4.     What are the regional dynamics that impact the growth of the IVD industry?
5.     What is the penetration of novel diagnostic solutions across the care continuum pathway?

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Purpose of this Growth Opportunity Study

Scope and Segmentation

5-step Process to Transformational Growth

Key Findings—How is this Market Important to You?

Market Engineering Measurements

8 Big Market Themes for APAC IVD Market

Research Methodology

Market Overview

APAC IVD Industry—Regional Perspective

Key Regulatory Trends—APAC

Market Drivers

Market Restraints

Industry Challenges

APAC IVD Market—Market Engineering Measurements

APAC IVD Market—Revenue Forecast

Market Snapshot

Market Share Analysis

Visioning Scenarios

Companies to Watch—JN Medsys

Companies to Watch—Quantum Biosystems

Companies to Watch—Medisensor Inc.

Companies to Watch—Clearbridge BioMedics

Companies to Watch—Volition Rx

Companies to Watch (Tech Innovation)

Mergers, Acquisitions, and Strategic Partnerships

Growth Opportunity—Digital Pathology

Growth Opportunity—Centralized Clinical Labs

Growth Opportunity—Super Specialty Clinics

Growth Opportunity—Diagnostic Data Management

Growth Opportunity—E-Commerce Model

Growth Opportunity—Clinical Lab Automation

Growth Opportunity—Clinical Trials

Growth Opportunity—Infectious Disease

Growth Opportunity—Molecular Diagnostics

Top Predictions for the APAC IVD Market

Strategic Imperatives for APAC IVD Companies

Percent Revenue by Country

Revenue by Country

China

Japan

South Korea

India

Australia

ASEAN Overview

Immunochemistry—Revenue Forecast

Immunochemistry—Key Trends

Immunochemistry—Opportunity Assessment and Case Study

Immunochemistry—Market Share Analysis

Immunochemistry—Snapshot of Market Participants

Molecular Diagnostics (MDx)—Revenue Forecast

Molecular Diagnostics (MDx)—Percent Revenue by Application

Molecular Diagnostics (MDx)—Key Trends

Molecular Diagnostics (MDx)—Market Share Analysis

Molecular Diagnostics (MDx)—Snapshot of Market Participants

SMBG—Revenue Forecast

SMBG—Key Trends

SMBG—Market Share Analysis

SMBG—Snapshot of Market Participants

POCT—Revenue Forecast

POCT—Percent Revenue by Application

POCT—Key Trends

POCT—Market Share Analysis

POCT—Snapshot of Market Participants

Hematology—Revenue Forecast

Hematology—Key Trends

Hematology—Case Study

Hematology—Market Share Analysis

Hematology—Snapshot of Market Participants

Tissue Diagnostics—Revenue Forecast

Tissue Diagnostics—Key Trends

Tissue Diagnostics—Market Share Analysis

Tissue Diagnostics—Snapshot of Market Participants

Hemostasis—Revenue Forecast

Hemostasis—Key Trends

Hemostasis—Market Share Analysis

Hemostasis—Snapshot of Market Participants

Clinical Microbiology—Revenue Forecast

Clinical Microbiology—Key Trends

Key Conclusions

Legal Disclaimer

List of Figures
  • 1. IVD Market: Key Market Drivers, APAC, 2017–2021
  • 2. IVD Market: Key Market Restraints, APAC, 2017–2021
  • 3. IVD Market: Industry Challenges, APAC, 2016–2021
  • 4. IVD Market: Market Engineering Measurements, APAC, 2016
  • 5. IVD Market: Multi-faceted Growth, APAC, 2016–2021
  • 6. IVD Market: Revenue by Country, APAC, 2016
  • 7. IVD Market: Key Market Participants in Immunochemistry, APAC, 2016
  • 8. IVD Market: Key Market Participants in Molecular Diagnostics, APAC, 2016
  • 9. IVD Market: Key Market Participants in SMBG, APAC, 2016
  • 10. IVD Market: Key Market Participants in POCT, APAC, 2016
  • 11. IVD Market: Key Market Participants in Hematology, APAC, 2016
  • 12. IVD Market: Key Market Participants in Tissue Diagnostics, APAC, 2016
  • 13. IVD Market: Key Market Participants in Hemostasis, APAC, 2016
List of Charts
  • 1. IVD Market: Market Engineering Measurements, APAC, 2016
  • 2. IVD Market: Revenue Forecast, APAC, 2015–2021
  • 3. IVD Market: Percent of Revenue by Participants, APAC, 2016
  • 4. IVD Market: Percent Revenue by Country, APAC, 2016
  • 5. IVD Market: Revenue Forecast for Immunochemistry, APAC, 2015–2021
  • 6. IVD Market: Market Share Analysis in Immunochemistry, APAC, 2016
  • 7. IVD Market: Revenue Forecast for Molecular Diagnostics, APAC, 2015–2021
  • 8. IVD Market: Percent Revenue by Application in Molecular Diagnostics, APAC, 2016
  • 9. IVD Market: Market Share Analysis in Molecular Diagnostics, APAC, 2016
  • 10. IVD Market: Revenue Forecast for SMBG, APAC, 2015–2021
  • 11. IVD Market: Market Share Analysis in Molecular Diagnostics, APAC, 2016
  • 12. IVD Market: Revenue Forecast for POCT, APAC, 2015–2021
  • 13. IVD Market: Percent Revenue by Application in POCT, APAC, 2016
  • 14. IVD Market: Market Share Analysis in POCT, APAC, 2016
  • 15. IVD Market: Revenue Forecast for Hematology, APAC, 2015–2021
  • 16. IVD Market: Improvement in Overall Performance Metrics Following Implementation of Lab Automation, APAC, 2017–2021
  • 17. IVD Market: Market Share Analysis in Hematology Diagnostics, APAC, 2016
  • 18. IVD Market: Revenue Forecast for Tissue Diagnostics, APAC, 2015–2021
  • 19. IVD Market: Market Share Analysis in Tissue Diagnostics, APAC, 2016
  • 20. IVD Market: Revenue Forecast for Hemostasis, APAC, 2015–2021
  • 21. IVD Market: Market Share Analysis in Hemostasis Diagnostics, APAC, 2016
  • 22. IVD Market: Revenue Forecast for Clinical Microbiology, APAC, 2015–2021
Related Research
The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions: o Immunochemistry o Self-monitoring Blood Glucose (SMBG) Meter o Hematology o Point-of-care Testing (POCT) o Tissue Diagnostics o Hemostasis o Clinical Microbiology o Molecular Diagnostics • Regional trends in APAC; it covers China, India, Japan, Australia, South Korea, and member states of the Association of Southeast Asian Nations (ASEAN) The APAC IVD industry is undergoing major transformation. Paradigm shifts in the Asian healthcare ecosystem are driving the future of the IVD industry with stellar growth rates and rampant uptake of innovative technologies. Market penetration of molecular diagnostic (MDx) tests in infectious disease diagnosis, laboratory automation for high throughput operational efficiency, and digital pathology are three major themes that will impact the future of clinical pathology in Asia. The spurt in the number of private healthcare sectors and market shift towards quality care, private insurance, and high demand for medical tourism have led Asia to be on par with western counterparts in terms of availability and access to novel technologies. However, given the huge potential and market opportunities, there remain significant challenges in the complex market with preferential demands in Asian countries and fluidic regulatory and market access networks that pose significant challenges for operating companies. The APAC IVD industry, worth $ 14.44 billion in 2016, is expected to reach $19.64 billion in 2021 growing at a CAGR of 6.3%. In molecular diagnostics, infectious disease has the highest market share of 72.0%, followed by oncology (14.3%), genetic disorders (10.0%), and pharmacogenomics (3.7%). Digital innovations in the IVD industry, such as digital pathology, precision medicine
More Information
No Index No
Podcast No
Table of Contents | Executive Dashboard~ || Purpose of this Growth Opportunity Study~ || Scope and Segmentation~ || 5-step Process to Transformational Growth~ || Key Findings—How is this Market Important to You?~ || Market Engineering Measurements~ || 8 Big Market Themes for APAC IVD Market~ | Growth Environment—Market Overview~ || Research Methodology~ || Market Overview~ || APAC IVD Industry—Regional Perspective~ || Key Regulatory Trends—APAC~ || Market Drivers~ || Market Restraints~ || Industry Challenges~ | Market Forecasts~ || APAC IVD Market—Market Engineering Measurements~ || APAC IVD Market—Revenue Forecast~ | Competitive Playbook~ || Market Snapshot~ || Market Share Analysis~ || Visioning Scenarios~ || Companies to Watch—JN Medsys~ || Companies to Watch—Quantum Biosystems~ || Companies to Watch—Medisensor Inc.~ || Companies to Watch—Clearbridge BioMedics~ || Companies to Watch—Volition Rx~ || Companies to Watch (Tech Innovation)~ || Mergers, Acquisitions, and Strategic Partnerships~ | Growth Pipeline, Strategy, and Implementation~ || Growth Opportunity—Digital Pathology~ || Growth Opportunity—Centralized Clinical Labs~ || Growth Opportunity—Super Specialty Clinics~ || Growth Opportunity—Diagnostic Data Management~ || Growth Opportunity—E-Commerce Model~ || Growth Opportunity—Clinical Lab Automation~ || Growth Opportunity—Clinical Trials~ || Growth Opportunity—Infectious Disease~ || Growth Opportunity—Molecular Diagnostics~ || Top Predictions for the APAC IVD Market~ || Strategic Imperatives for APAC IVD Companies~ | Regional Dynamics~ || Percent Revenue by Country~ || Revenue by Country~ || China~ || Japan~ || South Korea~ || India~ || Australia~ || ASEAN Overview~ | Segment Analysis~ || Immunochemistry—Revenue Forecast~ || Immunochemistry—Key Trends~ || Immunochemistry—Opportunity Assessment and Case Study~ || Immunochemistry—Market Share Analysis~ || Immunochemistry—Snapshot of Market Participants~ || Molecular Diagnostics (MDx)—Revenue Forecast~ || Molecular Diagnostics (MDx)—Percent Revenue by Application~ || Molecular Diagnostics (MDx)—Key Trends~ || Molecular Diagnostics (MDx)—Market Share Analysis~ || Molecular Diagnostics (MDx)—Snapshot of Market Participants~ || SMBG—Revenue Forecast~ || SMBG—Key Trends~ || SMBG—Market Share Analysis~ || SMBG—Snapshot of Market Participants~ || POCT—Revenue Forecast~ || POCT—Percent Revenue by Application~ || POCT—Key Trends~ || POCT—Market Share Analysis~ || POCT—Snapshot of Market Participants~ || Hematology—Revenue Forecast~ || Hematology—Key Trends~ || Hematology—Case Study~ || Hematology—Market Share Analysis~ || Hematology—Snapshot of Market Participants~ || Tissue Diagnostics—Revenue Forecast~ || Tissue Diagnostics—Key Trends~ || Tissue Diagnostics—Market Share Analysis~ || Tissue Diagnostics—Snapshot of Market Participants~ || Hemostasis—Revenue Forecast~ || Hemostasis—Key Trends~ || Hemostasis—Market Share Analysis~ || Hemostasis—Snapshot of Market Participants~ || Clinical Microbiology—Revenue Forecast~ || Clinical Microbiology—Key Trends~ | The Last Word~ || Key Conclusions~ || Legal Disclaimer~
List of Charts and Figures 1. IVD Market: Key Market Drivers, APAC, 2017–2021~ 2. IVD Market: Key Market Restraints, APAC, 2017–2021~ 3. IVD Market: Industry Challenges, APAC, 2016–2021~ 4. IVD Market: Market Engineering Measurements, APAC, 2016~ 5. IVD Market: Multi-faceted Growth, APAC, 2016–2021 ~ 6. IVD Market: Revenue by Country, APAC, 2016~ 7. IVD Market: Key Market Participants in Immunochemistry, APAC, 2016~ 8. IVD Market: Key Market Participants in Molecular Diagnostics, APAC, 2016~ 9. IVD Market: Key Market Participants in SMBG, APAC, 2016~ 10. IVD Market: Key Market Participants in POCT, APAC, 2016~ 11. IVD Market: Key Market Participants in Hematology, APAC, 2016~ 12. IVD Market: Key Market Participants in Tissue Diagnostics, APAC, 2016~ 13. IVD Market: Key Market Participants in Hemostasis, APAC, 2016~| 1. IVD Market: Market Engineering Measurements, APAC, 2016~ 2. IVD Market: Revenue Forecast, APAC, 2015–2021~ 3. IVD Market: Percent of Revenue by Participants, APAC, 2016~ 4. IVD Market: Percent Revenue by Country, APAC, 2016~ 5. IVD Market: Revenue Forecast for Immunochemistry, APAC, 2015–2021~ 6. IVD Market: Market Share Analysis in Immunochemistry, APAC, 2016~ 7. IVD Market: Revenue Forecast for Molecular Diagnostics, APAC, 2015–2021~ 8. IVD Market: Percent Revenue by Application in Molecular Diagnostics, APAC, 2016~ 9. IVD Market: Market Share Analysis in Molecular Diagnostics, APAC, 2016~ 10. IVD Market: Revenue Forecast for SMBG, APAC, 2015–2021~ 11. IVD Market: Market Share Analysis in Molecular Diagnostics, APAC, 2016~ 12. IVD Market: Revenue Forecast for POCT, APAC, 2015–2021~ 13. IVD Market: Percent Revenue by Application in POCT, APAC, 2016~ 14. IVD Market: Market Share Analysis in POCT, APAC, 2016~ 15. IVD Market: Revenue Forecast for Hematology, APAC, 2015–2021~ 16. IVD Market: Improvement in Overall Performance Metrics Following Implementation of Lab Automation, APAC, 2017–2021 ~ 17. IVD Market: Market Share Analysis in Hematology Diagnostics, APAC, 2016~ 18. IVD Market: Revenue Forecast for Tissue Diagnostics, APAC, 2015–2021~ 19. IVD Market: Market Share Analysis in Tissue Diagnostics, APAC, 2016~ 20. IVD Market: Revenue Forecast for Hemostasis, APAC, 2015–2021~ 21. IVD Market: Market Share Analysis in Hemostasis Diagnostics, APAC, 2016~ 22. IVD Market: Revenue Forecast for Clinical Microbiology, APAC, 2015–2021~
Lightbox Content World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019
Author Shaillender Muthukumaraswamy
Industries Healthcare
WIP Number P97C-01-00-00-00
Is Prebook No